FDA approves melanoma drug from Merck

September 5, 2014 5:30 PM

3 0

The sixth melanoma drug to be approved by the Food and Drug Administration (FDA) since 2011 is now in the market. This new melanoma drug was manufactured by Merck and it is called Keytruda – a drug that activates a patient’s own immune system to fight cancer cells and growths.

Melanoma is a rare skin cancer condition that is often deadly and malignant. Keytruda works by helping the body to identify cancer cells and to attack them to the points of destruction. It also appears to work where other skin cancer drugs have failed to help patients. It was tested on over 600 pati...

Read more

To category page